These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 3541131)
1. Prospects for the prevention and therapy of infections with the human immunodeficiency virus. Vogt M; Hirsch MS Rev Infect Dis; 1986; 8(6):991-1000. PubMed ID: 3541131 [TBL] [Abstract][Full Text] [Related]
2. Prospects of therapy for infections with human T-lymphotropic virus type III. Hirsch MS; Kaplan JC Ann Intern Med; 1985 Nov; 103(5):750-5. PubMed ID: 2413793 [TBL] [Abstract][Full Text] [Related]
3. [Chemotherapy and immunoprophylaxis of HIV infection]. Vogt M; Schooley RT; Hirsch MS Schweiz Rundsch Med Prax; 1986 Nov; 75(48):1471-5. PubMed ID: 2432642 [No Abstract] [Full Text] [Related]
4. Targets for antiviral therapy of human immunodeficiency virus infection. Jeffries DJ J Infect; 1989 Jan; 18 Suppl 1():5-13. PubMed ID: 2464649 [TBL] [Abstract][Full Text] [Related]
5. Development of antiviral agents for the treatment of human immunodeficiency virus infection. Tartaglione TA; Collier AC Clin Pharm; 1987 Dec; 6(12):927-40. PubMed ID: 3322638 [TBL] [Abstract][Full Text] [Related]
11. In vitro evaluation of mismatched double-stranded RNA (ampligen) for combination therapy in the treatment of acquired immunodeficiency syndrome. Montefiori DC; Robinson WE; Mitchell WM AIDS Res Hum Retroviruses; 1989 Apr; 5(2):193-203. PubMed ID: 2469450 [TBL] [Abstract][Full Text] [Related]
12. Animal models for HIV infection and AIDS: memorandum from a WHO meeting. Bull World Health Organ; 1988; 66(5):561-74. PubMed ID: 2850118 [TBL] [Abstract][Full Text] [Related]
13. Management of infectious and immunological complications of acquired immunodeficiency syndrome (AIDS). Current and future prospects. Tuazon CU; Labriola AM Drugs; 1987 Jan; 33(1):66-84. PubMed ID: 3545766 [TBL] [Abstract][Full Text] [Related]
14. Pathogenesis of human immunodeficiency virus infection and prospects for control. Ho DD; Kaplan JC Yale J Biol Med; 1987; 60(6):589-600. PubMed ID: 3324508 [TBL] [Abstract][Full Text] [Related]
15. Antiretroviral chemotherapy of human immunodeficiency virus infections other than with azidothymidine. Sachs MK Arch Intern Med; 1992 Mar; 152(3):485-501. PubMed ID: 1546911 [TBL] [Abstract][Full Text] [Related]
16. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs. Witvrouw M; De Clercq E Gen Pharmacol; 1997 Oct; 29(4):497-511. PubMed ID: 9352294 [TBL] [Abstract][Full Text] [Related]
17. Characteristics of a group of nonnucleoside reverse transcriptase inhibitors with structural diversity and potent anti-human immunodeficiency virus activity. Yang SS; Fliakas-Boltz V; Bader JP; Buckheit RW Leukemia; 1995 Oct; 9 Suppl 1():S75-85. PubMed ID: 7475321 [TBL] [Abstract][Full Text] [Related]
18. Animal models for the evaluation of drugs and vaccines for HIV infection and AIDS: report of a WHO Working Group. Esparza J Dev Biol Stand; 1990; 72():367-72. PubMed ID: 2282993 [No Abstract] [Full Text] [Related]
19. Correlations between the in vitro and in vivo activity of anti-HIV agents: implications for future drug development. Yarchoan R; Broder S J Enzyme Inhib; 1992; 6(1):99-111. PubMed ID: 1285306 [TBL] [Abstract][Full Text] [Related]
20. Biology of retroviruses: detection, molecular biology, and treatment of retroviral infection. Wells KH; Poiesz BJ J Am Acad Dermatol; 1990 Jun; 22(6 Pt 2):1175-95. PubMed ID: 2193945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]